AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vaxcyte, Inc. Director's Dealing 2026

Jan 16, 2026

31100_dirs_2026-01-16_215be93c-0d43-4139-bc93-304aba828de2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2026-01-14

Reporting Person: PICKERING GRANT (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-14	Common Stock	G	100000	—	Disposed	400908	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	136215	Indirect
Common Stock	136215	Indirect

Footnotes

F1: The reported transaction involves the Reporting Person's transfer of shares to an irrevocable trust for estate planning purposes. The Reporting Person no longer has a pecuniary interest in the shares and therefore disclaims beneficial ownership.

F2: Shares are held directly by a trust for the benefit of the Reporting Person's son.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.